时间驱动作业成本法分析乳腺癌放疗分次方案的经济影响
本研究采用时间驱动作业成本法(TDABC)比较早期乳腺癌加速全乳照射(AWBI)与常规全乳照射(CWBI)的交付成本与报销。结果显示AWBI总成本6965美元,CWBI为9267美元,差异2302美元(25%);报销差异为3243美元(25%)。TDABC可用于评估不同分次方案的资源需求,帮助识别降低成本和提高效率的机会。
要点
- AWBI总成本6965美元,CWBI为9267美元,差异2302美元(25%)。
- AWBI报销9665美元,CWBI为12908美元,差异3243美元(25%)。
核心结论
- TDABC可评估不同放疗分次方案的资源需求,AWBI成本显著低于CWBI,主要因每日治疗次数减少。
研究设计与样本
- 基于时间驱动作业成本法(TDABC)的成本分析,针对早期乳腺癌AWBI(42.5 Gy/16次+10 Gy/4次推量)和CWBI(50 Gy/25次+10 Gy/5次推量)两种方案构建流程地图。
- 成本按人员、材料、设备、空间和设施的单位时间总成本及产能使用比例确定;报销基于2019年CMS医师费用表数据库计算所有可计费事件的总和。
主要发现
- AWBI总成本6965美元,CWBI总成本9267美元,差异2302美元(25%)。
- AWBI总报销9665美元,CWBI总报销12908美元,差异3243美元(25%)。
- 总成本的55%至60%与人员相关,其余与材料、设施、空间和设备相关。
临床怎么用
- TDABC可用于评估不同放疗分次方案的资源需求,识别降低成本和提高临床效率的机会,支持价值导向的医疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Value-based care is increasingly informing treatment decisions in radiation oncology. Although reimbursement differences have been examined for accelerated whole breast irradiation (AWBI) and conventional whole breast irradiation (CWBI), the cost of care delivery is poorly understood. This article describes our experience evaluating costs for altered fractionation in early-stage breast cancer using a time-driven activity-based costing (TDABC) model. METHODS AND MATERIALS: Process maps were developed for 2 treatment regimens, AWBI (42.5 Gy in 16 fractions + 10 Gy in 4 fractions boost) and CWBI (50 Gy in 25 fractions + 10 Gy in 5 fractions boost). Cost was determined based on aggregate cost of personnel, materials, equipment, space, and utilities per unit time and based on the relative proportion of capacity used. The total reimbursement for each regimen was calculated as the aggregate of all billable events during a course of radiation therapy, based on the 2019 Centers for Medicare & Medicaid Services physician fee schedule database. RESULTS: The total cost of delivering courses of AWBI and CWBI was $6965 and $9267, respectively, a difference of $2302 (25%). Eighty-six percent of this difference was related to a lower cost of delivering daily treatments. The total reimbursement for AWBI or CWBI was $9665 or $12,908, respectively, a difference of $3243 (25%). Overall, 55% to 60% of total costs were related to personnel, with the remainder related to materials, utilities, space, and equipment. CONCLUSIONS: This analysis shows how TDABC can be used to evaluate resource requirements for different radiation therapy fractionation schedules. We found a substantially lower cost for AWBI compared with CWBI, primarily resulting from fewer daily treatments. As the emphasis in health care shifts toward value-based care, TDABC can help identify opportunities to reduce costs and increase clinical efficiency.
引用
- Dziemianowicz M, Burmeister J, Dominello M, et al. Examining the Financial Impact of Altered Fractionation in Breast Cancer: An Analysis Using Time-Driven Activity-Based Costing. Pract Radiat Oncol. 2021. PMID: 33476840. doi:10.1016/j.prro.2021.01.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。